We are a research-based Norwegian company focused on bringing precision cancer medicine and diagnosis into reality of Norway for clinicians and cancer patients. We provide gene testing for cancer patients using cutting edge technologies such as sequencing and bioinformatics. We believe in helping clinicians and saving lives of Norwegian cancer patients with precision medicine and diagnosis. For this good cause, We have become a cancer genetic testing facilitator and developing digital applications for genetic diagnostics and precision medicine.
We believe in the scientific facts that every individual has the unique genetic codes in the genome. The 4-letter code (A, T, G and C) is the language of genome. The errors in these codes can have serious consequences, such as cancer. These error are called variants or mutations, etc. The next generation high-throughput sequencing technologies have enabled us to find the disease-causing codes at the genome and/or transcriptome levels; therefore, we are focused on deciphering these genetic codes using various bioinformatics approaches and find disease causing events (mutations, gene-fusions, differentially expressed genes) and annotate them for precision medicine.
Our mission is: “Saving Lives of Cancer Patients” using precision medicine and providing best clinical gene testing for precision diagnosis and treatment of cancer. In addition, we also provide digital solutions to help patients and researchers.